Skip to main content
. 2012 Sep 19;3(9):1036–1048. doi: 10.18632/oncotarget.663

Figure 6. STAT-3 blockade in GL261 tumors treated with cediranib blocks the maintenance of stem cell properties.

Figure 6

(A) Representative light microscopy images showing immunohistochemical detection of nestin (red) and nuclei (blue). All images were taken at 400 x. (B) Bar graph demonstrating the average percentage of nestin-positive cells in the GL261 murine model system treated either with vehicle (control), cediranib, AZD1490 or the combination. *P=0.008, #P=0.009.